MICHAEL RHODES: Open Payments
NPI 1396499935 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,505 in 165 payments from 23 companies in 2025. Trend: 2023 $3,469 · 2024 $3,952 · 2025 $3,505
Food & beverage: $3,505
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $991 |
| UCB, Inc. | 21 | $644 |
| Amgen Inc. | 17 | $276 |
| PFIZER INC. | 11 | $205 |
| Mallinckrodt Hospital Products Inc. | 9 | $183 |
| AstraZeneca Pharmaceuticals LP | 8 | $159 |
| Janssen Biotech, Inc. | 6 | $137 |
| Radius Health, Inc. | 5 | $127 |
| Organon LLC | 5 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $94 |
Products named: RINVOQ, Bimzelx, SKYRIZI, XELJANZ, ACTHAR, TREMFYA, KRYSTEXXA, ORENCIA.
Industry payments across AZ — which companies pay providers there.
